Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Elise E. Drouin"'
Autor:
Daniel J. Wallace, Thomas Dörner, David S. Pisetsky, Jorge Sanchez‐Guerrero, Anand C. Patel, Dana Parsons‐Rich, Claire Le Bolay, Elise E. Drouin, Amy H. Kao, Hans Guehring, Maria Dall'Era
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 1, Pp 38-48 (2023)
Objective Evobrutinib is a highly selective, orally administered Bruton's tyrosine kinase (BTK) inhibitor. The objective of this phase II, multicenter, randomized, double‐blind, placebo‐controlled trial was to evaluate the efficacy and safety of
Externí odkaz:
https://doaj.org/article/fbfb7923863e4170999f2062f9b263dc
Autor:
Daniel J. Wallace, Thomas Dörner, David S. Pisetsky, Jorge Sanchez‐Guerrero, Anand C. Patel, Dana Parsons‐Rich, Claire Le Bolay, Elise E. Drouin, Amy H. Kao, Hans Guehring, Maria Dall'Era
Publikováno v:
ACR Open Rheumatology. 5:38-48
Autor:
Amit Bar-Or, Anne H. Cross, Anthony Cunningham, Yann Hyvert, Andrea Seitzinger, Elise E. Drouin, Nektaria Alexandri, Davorka Tomic, Xavier Montalban
Publikováno v:
Sunday, April 23.
Autor:
Randi B Gombos, Ana Gonzalez, Mariana Manrique, Dhan Chand, David Savitsky, Benjamin Morin, Ekaterina Breous-Nystrom, Christopher Dupont, Rebecca A Ward, Cornelia Mundt, Benjamin Duckless, Hao Tang, Mark A Findeis, Andrea Schuster, Jeremy D Waight, Dennis Underwood, Christopher Clarke, Gerd Ritter, Taha Merghoub, David Schaer, Jedd D Wolchok, Marc van Dijk, Jennifer S Buell, Jean-Marie Cuillerot, Robert Stein, Elise E Drouin, Nicholas S Wilson
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0191926 (2018)
CTLA-4 and CD28 exemplify a co-inhibitory and co-stimulatory signaling axis that dynamically sculpts the interaction of antigen-specific T cells with antigen-presenting cells. Anti-CTLA-4 antibodies enhance tumor-specific immunity through a variety o
Externí odkaz:
https://doaj.org/article/a2c5e638342c4ecea28b08aa00701413
Autor:
Daniel J, Wallace, Thomas, Dörner, David S, Pisetsky, Jorge, Sanchez-Guerrero, Anand C, Patel, Dana, Parsons-Rich, Claire, Le Bolay, Elise E, Drouin, Amy H, Kao, Hans, Guehring, Maria, Dall'Era
Publikováno v:
ACR open rheumatologyREFERENCES.
Evobrutinib is a highly selective, orally administered Bruton's tyrosine kinase (BTK) inhibitor. The objective of this phase II, multicenter, randomized, double-blind, placebo-controlled trial was to evaluate the efficacy and safety of evobrutinib in
Autor:
Catherine E. Costello, Yu Huang, Jiyang Zhang, Elise E. Drouin, Chunxiang Yao, Allen C. Steere, Deborah R. Leon, Qi Wang
Publikováno v:
Journal of Proteome Research. 16:122-136
HLA-DR-molecules are highly expressed in synovial tissue (ST), the target of the immune response in chronic inflammatory forms of arthritis. Here, we used LC-MS/MS to identify HLA-DR-presented self-peptides in cells taken directly from clinical sampl
Autor:
Sheila L. Arvikar, Elise E. Drouin, Annalisa Pianta, Klemen Strle, Jameson T. Crowley, Allen C. Steere, Catherine E. Costello
Publikováno v:
Clinical Immunology. 160:336-341
In this study, autoantibody responses to annexin A2 were found in 11-15% of 278 patients with Lyme disease, including in those with erythema migrans (EM), an early sign of the illness, and in those with antibiotic-responsive or antibiotic-refractory
Autor:
Allen C. Steere, Elise E. Drouin, Catherine E. Costello, Klemen Strle, Jameson T. Crowley, Annalisa Pianta, Qi Wang
Publikováno v:
Journal of Infectious Diseases. 212:1841-1850
To discover novel autoantigens associated with Lyme arthritis (LA), we identified T-cell epitopes presented in vivo by human leukocyte antigen (HLA)-DR molecules in patients' inflamed synovial tissue or joint fluid and tested each epitope for autorea
Autor:
Klemen Strle, Sheila L. Arvikar, Qi Wang, Elise E. Drouin, Allen C. Steere, Catherine E. Costello, Annalisa Pianta
Objective Prevotella copri, an intestinal microbe, may overexpand in stool samples from patients with new-onset rheumatoid arthritis (RA), but it is not yet clear whether the organism has immune relevance in RA pathogenesis. Methods HLA–DR–presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2072b6adfba1ec79ac2f07e94c293010
https://europepmc.org/articles/PMC5406252/
https://europepmc.org/articles/PMC5406252/
Autor:
Elise E. Drouin, Diana Londoño, Klemen Strle, John M. Aversa, Diego Cadavid, Gail McHugh, Allen C. Steere
Publikováno v:
Arthritis & Rheumatology. 66:2124-2133
Lyme disease in the northeastern United States is caused by the tick-transmitted spirochete, Borrelia burgdorferi (1). The most common late manifestation of the infection is Lyme arthritis, which often affects one or both knees (2). Most patients can